According to ImmunoPrecise Antibodies's latest financial reports the company's current EPS (TTM) is -$0.62. In 2022 the company made an earnings per share (EPS) of -$0.85 a decrease over its 2021 EPS that were of -$0.65.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.62 | -26.94% |
2022 | -$0.85 | 30.54% |
2021 | -$0.65 | 364.7% |
2020 | -$0.14 | -71.26% |
2019 | -$0.49 | 13.65% |
2018 | -$0.43 | -65.95% |
2017 | -$1.26 | |
2015 | -$0.06633 | 5.17% |
2014 | -$0.06307 | -150.23% |
2013 | $0.13 | -169.38% |
2012 | -$0.18 | -60.99% |
2011 | -$0.46 | -95.24% |
2010 | -$9.74 | 454% |
2009 | -$1.76 | 54.82% |
2008 | -$1.14 | -63.13% |
2007 | -$3.08 | 92.84% |
2006 | -$1.60 | -278.94% |
2005 | $0.89 | -138.69% |
2004 | -$2.31 | -20.52% |
2003 | -$2.90 | 45.39% |
2002 | -$2.00 | 56.64% |
2001 | -$1.27 |